Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)

NCT04809623 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision to terminate study.

Conditions

Cutaneous Lupus Erythematosus

Interventions

DRUG: Edecesertib
DRUG: Placebo
DRUG: Standard of Care

Sponsor

Gilead Sciences